Zobrazeno 1 - 10
of 167
pro vyhledávání: '"Sleiman, N."'
Autor:
Verlingue L; Gustave Roussy Institute of Oncology, Villejuif, France., Italiano A; Institut Bergonié Cancer Center, Bordeaux, France., Prenen H; Antwerp University Hospital, Edegem, Belgium., Guerra Alia EM; Ramón y Cajal University Hospital, Madrid, Spain., Tosi D; Montpellier Cancer Institute, Montpellier, France., Perets R; Division of Oncology, Clinical Research Institute at Rambam, Rambam Medical Center, Haifa, Israel., Lugowska I; Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Moiseyenko V; Clinical Scientific and Practical Center, Saint-Petersburg, Russia., Gumus M; Istanbul Medeniyet University, Istanbul, Turkey., Arslan C; Izmir Economy University Medical Point Hospital, Izmir, Turkey., Lindsay CR; The Christie NHS Foundation Trust, Manchester, UK., Deva S; Auckland City Hospital, Auckland, New Zealand., Taus Á; Medical Oncology Department Hospital del Mar, CIBERONC, Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain., Oaknin A; Gynaecologic Cancer Programme, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Rottey S; Gent University Hospital, Gent, Belgium., Cicin I; Trakya University, Edirne, Turkey., Goksu SS; Akdeniz University, Antalya, Turkey., Smolin A; Burdenko Main Military Hospital, Moscow, Russia., Roselló-Keränen S; INCLIVA Biomedical Research Institute, Hospital Clinico Universitario de Valencia, Valencia, Spain., Habigt C; Roche Pharma Research and Early Development, Penzburg, Germany., Marbach D; Pharmaceutical Sciences, Roche Innovation Center, Basel, Switzerland., Boetsch C; Pharmaceutical Sciences, Roche Innovation Center, Basel, Switzerland., Dejardin D; Roche Product Development, Data Science, Roche Innovation Center, Basel, Switzerland., Sleiman N; Roche Product Development, Data Science, Roche Innovation Center, Basel, Switzerland., Evers S; Roche Pharma Research and Early Development, Discovery & Translational Area Oncology, Roche Innovation Center, Basel, Switzerland., Richard M; Roche Pharma Research and Early Development, Discovery & Translational Area Oncology, Roche Innovation Center Zurich, Schlieren, Switzerland., Ardeshir C; Roche Products Ltd, Welwyn Garden City, UK., Charo J; Roche Pharma Research and Early Development, Discovery & Translational Area Oncology, Roche Innovation Center Zurich, Schlieren, Switzerland., Kraxner A; Roche Pharma Research and Early Development, Discovery & Translational Area Oncology, Roche Innovation Center, Basel, Switzerland., Teichgräber V; Roche Pharma Research and Early Development, Discovery & Translational Area Oncology, Roche Innovation Center, Basel, Switzerland., Keshelava N; Roche Pharma Research and Early Development, Discovery & Translational Area Oncology, Roche Innovation Center Zurich, Schlieren, Switzerland., Dziadziuszko R; Medical University of Gdansk, Gdansk, Poland. Electronic address: rafal.dziadziuszko@gumed.edu.pl.
Publikováno v:
EBioMedicine [EBioMedicine] 2024 Nov; Vol. 109, pp. 105374. Date of Electronic Publication: 2024 Oct 11.
Autor:
Hansen AR; Princess Margaret Hospital, Brisbane, Queensland, Australia., Gomez-Roca CA; Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France., Robbrecht DGJ; Erasmus MC Cancer Institute, Rotterdam, Netherlands., Verlingue L; Centre Léon Bérard, Lyon, France., Italiano A; Institut Bergonié, Bordeaux, France., Bauman JE; George Washington University, Washington, DC, United States., Steeghs N; Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands., Prenen H; University Hospital Antwerp, Edegem, Belgium., Fayette J; Leon Berard, LYON, France., Spicer J; King's College London, London, United Kingdom., Niu J; Banner MD Anderson Cancer Center, Gilbert, Arizona, United States., Habigt C; Roche Innovation Center Munich, Germany., Schneider M; Roche Pharma Research and Early Development, Basel, Switzerland., Evers S; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Sleiman N; Pharmaceutical Sciences, Roche Innovation Center, Basel, Switzerland., Dejardin D; Roche (Switzerland), Basel, Switzerland., Ardeshir C; Roche Products Ltd, United Kingdom., Schmid D; Roche Pharma Research and Early Development, Early Clinical Development Oncology, Roche Innovation Center, Penzberg, Germany., Boetsch C; Roche (Switzerland), Basel, Switzerland., Charo J; Roche (Switzerland), Schlieren, Zurich, Switzerland., Kraxner A; Roche (Switzerland), Basel, Switzerland., Teichgräber V; Roche (Switzerland), Basel, Switzerland., Keshelava N; Roche Pharma Research and Early Development, Discovery & Translational Area Oncology, Roche Innovation Center Zurich, Schlieren, Switzerland., Bonomi MR; James Cancer Hospital, Columbus, OH, United States.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Oct 18. Date of Electronic Publication: 2024 Oct 18.
Infectious acute respiratory failure in patients under 5 years of age: a retrospective cohort study.
Autor:
Rifai M; PICU, Hopital Raymond-Poincare, Garches, France mahmoud.rifai@hotmail.fr., Bergounioux J; PICU, Hopital Raymond-Poincare, Garches, France., Sleiman N; PICU, Hopital Raymond-Poincare, Garches, France., Ismail J; Cardiology, Hôpital André Mignot, Le Chesnay, France., Zini J; PICU, Hopital Raymond-Poincare, Garches, France.
Publikováno v:
BMJ paediatrics open [BMJ Paediatr Open] 2024 Sep 25; Vol. 8 (1). Date of Electronic Publication: 2024 Sep 25.
Autor:
Prenen H; Antwerp University Hospital, Edegem, Belgium., Deva S; Auckland City Hospital, Auckland, New Zealand., Keam B; Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea., Lindsay CR; The Christie NHS Foundation Trust, Manchester, United Kingdom., Lugowska I; Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Yang JC; National Taiwan University Hospital, National Taiwan University Cancer Center, Taipei City, Taiwan., Longo F; Ramón y Cajal University Hospital, IRYCIS, Universidad Alcala, CIBERONC, Madrid, Spain., de Miguel M; START-Madrid-FJD, Hospital Universitario HM Sanchinarro, Madrid, Spain., Ponz-Sarvise M; Cancer Center, Clínica Universidad de Navarra, Pamplona, Spain., Ahn MJ; Samusung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea., Gumus M; Istanbul Medeniyet University, Istanbul, Turkey., Champiat S; Département d'Innovation Thérapeutique et d'Essais Précoces (DITEP), Gustave Roussy, Villejuif, France., Italiano A; Institut Bergonié Cancer Center, Bordeaux, France., Salas S; Aix-Marseille Université, Marseille, France., Perets R; Division of Oncology, Clinical Research Institute at Rambam, Rambam Medical Center, Haifa, Israel., Arslan C; Izmir Economy University Medical Point Medical Hospital, Izmir, Turkey., Cho BC; Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea., Evers S; Roche Pharma Research and Early Development, Discovery and Translational Area Oncology, Roche Innovation Center, Basel, Switzerland., Boetsch C; Pharmaceutical Sciences, Roche Innovation Center, Basel, Switzerland., Marbach D; Pharmaceutical Sciences, Roche Innovation Center, Basel, Switzerland., Dejardin D; Biostatistics, Product Development, Roche Innovation Center, Basel, Switzerland., Sleiman N; Biostatistics, Product Development, Roche Innovation Center, Basel, Switzerland., Ardeshir C; Roche Products Ltd., Welwyn Garden City, United Kingdom., Richard M; Roche Pharma Research and Early Development, Discovery and Translational Area Oncology, Roche Innovation Center, Basel, Switzerland., Charo J; Roche Pharma Research and Early Development, Discovery and Translational Area Oncology, Roche Innovation Center Zurich, Schlieren, Switzerland., Kraxner A; Roche Pharma Research and Early Development, Discovery and Translational Area Oncology, Roche Innovation Center, Basel, Switzerland., Keshelava N; Roche Pharma Research and Early Development, Discovery and Translational Area Oncology, Roche Innovation Center Zurich, Schlieren, Switzerland., Teichgräber V; Roche Pharma Research and Early Development, Discovery and Translational Area Oncology, Roche Innovation Center, Basel, Switzerland., Moreno V; START-Madrid-FJD, Hospital Fundación Jimenez Diaz, Madrid, Spain.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Jul 15; Vol. 30 (14), pp. 2945-2953.
Autor:
Steeghs N; Netherlands Cancer Institute, Amsterdam, the Netherlands., Gomez-Roca C; Institut Universitaire du Cancer, Toulouse, France., Rohrberg KS; Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark., Mau-Sørensen M; Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark., Robbrecht D; Erasmus University Medical Center, Rotterdam, the Netherlands., Tabernero J; Vall d'Hebron Hospital Campus and Institute of Oncology (VHIO), CIBERONC, Barcelona, Spain., Ahmed S; University Hospitals of Leicester NHS Trust, Leicester, United Kingdom., Rodríguez-Ruiz ME; Clinica Universidad de Navarra, CIBERONC, Pamplona, Spain., Ardeshir C; Roche Products Ltd., Welwyn Garden City, United Kingdom., Schmid D; Roche Pharma Research and Early Development, Early Clinical Development Oncology, Roche Innovation Center, Munich, Germany., Sleiman N; Pharmaceutical Sciences, Roche Innovation Center, Basel, Switzerland., Watson C; A4P Consulting Ltd., Sandwich, United Kingdom., Piper-Lepoutre H; Pharmaceutical Sciences, Roche Innovation Center, Basel, Switzerland., Dejardin D; Pharmaceutical Sciences, Roche Innovation Center, Basel, Switzerland., Evers S; Roche Pharma Research and Early Development, Early Clinical Development Oncology, Roche Innovation Center, Basel, Switzerland., Boetsch C; Pharmaceutical Sciences, Roche Innovation Center, Basel, Switzerland., Charo J; Roche Pharma Research and Early Development, Early Clinical Development Oncology, Roche Innovation Center Zurich, Schlieren, Switzerland., Teichgräber V; Netherlands Cancer Institute, Amsterdam, the Netherlands.; Institut Universitaire du Cancer, Toulouse, France., Melero I; Clinica Universidad de Navarra, CIBERONC, Pamplona, Spain.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Jul 01; Vol. 30 (13), pp. 2693-2701.
Autor:
Sleiman N; Université de Franche-Comté, CNRS, Institut UTINAM UMR 6213, F-25000 Besançon, France; ICSM UMR 5257 - CEA, Univ Montpellier, CNRS, ENSCM, Bagnols-sur-Cèze, France; IRT M2P, Metz, France., Pflieger R; ICSM UMR 5257 - CEA, Univ Montpellier, CNRS, ENSCM, Bagnols-sur-Cèze, France., Hallez L; Université de Franche-Comté, CNRS, Institut UTINAM UMR 6213, F-25000 Besançon, France., Nikitenko SI; ICSM UMR 5257 - CEA, Univ Montpellier, CNRS, ENSCM, Bagnols-sur-Cèze, France., Hihn JY; Université de Franche-Comté, CNRS, Institut UTINAM UMR 6213, F-25000 Besançon, France; IRT M2P, Metz, France. Electronic address: jean-yves.hihn@univ-fcomte.fr.
Publikováno v:
Ultrasonics sonochemistry [Ultrason Sonochem] 2024 Mar; Vol. 104, pp. 106836. Date of Electronic Publication: 2024 Feb 28.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Jia Y; IGFL, CNRS UMR5242, ENS-Lyon, UCBL-1, INRA USC1370, 32 Av. Tony Garnier, 69007 Lyon, France.; Department of Developmental and Cell Biology, University of California, Irvine, CA 92697, USA., Reboulet J; IGFL, CNRS UMR5242, ENS-Lyon, UCBL-1, INRA USC1370, 32 Av. Tony Garnier, 69007 Lyon, France.; LiPiCs, 46 Allée d'Italie, 69007 Lyon, France., Gillet B; IGFL, CNRS UMR5242, ENS-Lyon, UCBL-1, INRA USC1370, 32 Av. Tony Garnier, 69007 Lyon, France., Hughes S; IGFL, CNRS UMR5242, ENS-Lyon, UCBL-1, INRA USC1370, 32 Av. Tony Garnier, 69007 Lyon, France., Forcet C; IGFL, CNRS UMR5242, ENS-Lyon, UCBL-1, INRA USC1370, 32 Av. Tony Garnier, 69007 Lyon, France., Tribollet V; IGFL, CNRS UMR5242, ENS-Lyon, UCBL-1, INRA USC1370, 32 Av. Tony Garnier, 69007 Lyon, France., Hajj Sleiman N; IGFL, CNRS UMR5242, ENS-Lyon, UCBL-1, INRA USC1370, 32 Av. Tony Garnier, 69007 Lyon, France., Kundlacz C; IGFL, CNRS UMR5242, ENS-Lyon, UCBL-1, INRA USC1370, 32 Av. Tony Garnier, 69007 Lyon, France., Vanacker JM; IGFL, CNRS UMR5242, ENS-Lyon, UCBL-1, INRA USC1370, 32 Av. Tony Garnier, 69007 Lyon, France., Bleicher F; IGFL, CNRS UMR5242, ENS-Lyon, UCBL-1, INRA USC1370, 32 Av. Tony Garnier, 69007 Lyon, France., Merabet S; IGFL, CNRS UMR5242, ENS-Lyon, UCBL-1, INRA USC1370, 32 Av. Tony Garnier, 69007 Lyon, France.
Publikováno v:
Cells [Cells] 2023 Jan 03; Vol. 12 (1). Date of Electronic Publication: 2023 Jan 03.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
El Osta N; Centre de Recherche en Odontologie Clinique (CROC), Université Clermont Auvergne, 63000 Clermont-Ferrand, France.; Faculty of Medicine, Saint Joseph University of Beirut, Beirut 111, Lebanon., Wehbe A; Faculty of Medicine, Saint Joseph University of Beirut, Beirut 111, Lebanon., Sleiman N; Faculty of Medicine, Saint Joseph University of Beirut, Beirut 111, Lebanon., Drancourt N; Centre de Recherche en Odontologie Clinique (CROC), Université Clermont Auvergne, 63000 Clermont-Ferrand, France.; CHU of Clermont-Ferrand, Service d'Odontologie, 63003 Clermont-Ferrand, France., El Osta L; Faculty of Medicine, Saint Joseph University of Beirut, Beirut 111, Lebanon., Hennequin M; Centre de Recherche en Odontologie Clinique (CROC), Université Clermont Auvergne, 63000 Clermont-Ferrand, France.; CHU of Clermont-Ferrand, Service d'Odontologie, 63003 Clermont-Ferrand, France.
Publikováno v:
International journal of environmental research and public health [Int J Environ Res Public Health] 2022 Nov 16; Vol. 19 (22). Date of Electronic Publication: 2022 Nov 16.